1465908-70-6
1465908-70-6
Chemical Structure
Tasipimidine
- CAS No.: 1465908-70-6
- Formula:C13H16N2O2
- Molecular Weight:232.28
IUPAC Name: 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1H-imidazole
InChIKey: GHIKYGQWBRHEGU-UHFFFAOYSA-N
SMILES: COC1=C2CCOC(C3=NCCN3)C2=CC=C1
Biological Activity: Tasipimidine is an orally active and selective α2A-adrenoceptor agonist with a pEC50 of 7.57 for human α2A-adrenoceptors and an EC50 of 5.7 nM for rat α2-adrenoceptor. Tasipimidine can be utilized in research related to situational anxiety and fear[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Tasipimidine | Tasipimidine is an orally active and selective α2A-adrenoceptor agonist with a pEC50 of 7.57 for human α2A-adrenoceptors and an EC50 of 5.7 nM for rat α2-adrenoceptor. Tasipimidine can be utilized in research related to situational anxiety and fear. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Lehtimäki J, et al. Tasipimidine-the pharmacological profile of a novel orally active selective α2A-adrenoceptor agonist. Eur J Pharmacol. 2022 May 15;923:174949. [Content Brief]
- [2]. Korpivaara M, et al. Tasipimidine, a novel orally administered alpha-2 adrenoceptor agonist, alleviates canine acute anxiety associated with owner departure—A pilot study. Journal of Veterinary Behavior, 2022, 58: 54-61.
